AN OPEN-LABEL EXTENSION STUDY OF VOLANESORSEN ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH FAMILIAL CHYLOMICRONEMIA (FCS)

Registry ID

ISIS 304801-CS7

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

AKCEA THERAPEUTICS INC

Start date

2017-06-02

Completion date

2019-12-05

Last update

2016-03-30

Conditions

• FAMILIAL CHYLOMICRONEMIA SYNDROME

Related clinical trials

• AN OPEN-LABEL SAFETY STUDY OF AKCEA-APOCIII-LRX ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME (FCS) PREVIOUSLY TREATED WITH VOLANESORSEN (ISIS 304801)
• AN OPEN-LABEL EXTENSION STUDY OF AKCEA-APOCIII-LRX ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME (FCS)

View on source registry